Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue SUPPL 1, 2013, Pages 132-137

  Han, Qiuju ^a   Lan, Peixiang ^a   Zhang, Jian ^a   Zhang, Cai ^a   Tian, Zhigang ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

HBV; Immune tolerance; Intrinsic immunity

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HEPATITIS B VACCINE; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INNATE IMMUNITY; LIVER BIOPSY; LIVER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; VACCINATION;

EID: 84880396353     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12034     Document Type: Review

References (42)

1. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 2000; 64: 51-68.
2. Sun L, Liu S, Chen ZJ. SnapShot: pathways of antiviral innate immunity. Cell 2010; 140: 436-436e2.
3. Wu J, Lu M, Meng Z etal. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 2007; 46: 1769-1778.
4. Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J. Gen. Virol. 2010; 91: 2080-2090.
5. Wu J, Meng Z, Jiang M etal. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 2009; 49: 1132-1140.
6. Visvanathan K, Skinner NA, Thompson AJ etal. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45: 102-110.
7. Wang FS, Xing LH, Liu MX etal. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J. Gastroenterol. 2001; 7: 537-541.
8. Kumar M, Jung SY, Hodgson AJ, Madden CR, Qin J, Slagle BL. Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J. Virol. 2011; 85: 987-995.
9. Wei C, Ni C, Song T etal. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J. Immunol. 2010; 185: 1158-1168.
10. Wang X, Li Y, Mao A, Li C, Tien P. Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex. Cell. Mol. Immunol. 2010; 7: 341-348.
11. Zhang Z, Protzer U, Hu Z, Jacob J, Liang TJ. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J. Virol. 2004; 78: 4566-4572.
12. Fernandez M, Quiroga JA, Carreno V. Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J. Gen. Virol. 2003; 84: 2073-2082.
13. Oliviero B, Varchetta S, Paudice E etal. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009; 137: 1151-1160, 60 e1-7.
14. Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J. Hepatol. 2011; 54: 209-218.
15. Sun C, Fu B, Gao Y etal. TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012; 8: e1002594.
16. Peppa D, Micco L, Javaid A etal. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 2010; 6: e1001227.
17. Tang KF, Chen M, Xie J etal. Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells. Med. Microbiol. Immunol. 2009; 198: 27-32.
18. Fisicaro P, Valdatta C, Massari M etal. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010; 138: 682-693, 93 e1-4.
19. Zeissig S, Murata K, Sweet L etal. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat. Med. 2012; 18: 1060-1068.
20. Ito H, Ando K, Ishikawa T etal. Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance. Int. Immunol. 2008; 20: 869-879.
21. de Lalla C, Galli G, Aldrighetti L etal. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J. Immunol. 2004; 173: 1417-1425.
22. Jiang X, Zhang M, Lai Q etal. Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B. PLoS ONE 2011; 6: e28871.
23. van der Molen RG, Sprengers D, Binda RS etal. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004; 40: 738-746.
24. Woltman AM, Op den Brouw ML, Biesta PJ, Shi CC, Janssen HL. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 2011; 6: e15324.
25. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J. Clin. Immunol. 2004; 24: 637-646.
26. Shi CC, Tjwa ET, Biesta PJ etal. Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells. J. Viral Hepat. 2012; 19: e26-33.
27. Untergasser A, Zedler U, Langenkamp A etal. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 2006; 43: 539-547.
28. van der Burg SH, Arens R, Melief CJ. Immunotherapy for persistent viral infections and associated disease. Trends Immunol. 2011; 32: 97-103.
29. Boni C, Fisicaro P, Valdatta C etal. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 2007; 81: 4215-4225.
30. Maier H, Isogawa M, Freeman GJ, Chisari FV. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J. Immunol. 2007; 178: 2714-2720.
31. Frebel H, Richter K, Oxenius A. How chronic viral infections impact on antigen-specific T-cell responses. Eur. J. Immunol. 2010; 40: 654-663.
32. Schurich A, Khanna P, Lopes AR etal. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011; 53: 1494-1503.
33. Bertoletti A, Costanzo A, Chisari FV etal. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 1994; 180: 933-943.
34. Ju Y, Hou N, Zhang XN etal. Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8+ T cells in a mouse model of hepatitis B virus infection. Cell. Mol. Immunol. 2009; 6: 35-43.
35. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008; 123: 57-65.
36. Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity 2009; 31: 145-157.
37. Bertoletti A, Tan AT, Gehring AJ. HBV-Specific adaptive immunity. Viruses 2009; 1: 91-103.
38. Vincent IE, Zannetti C, Lucifora J etal. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS ONE 2011; 6: e26315.
39. Kang EH, Kown TY, Oh GT etal. The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B virus-e antigen. Antiviral Res. 2006; 72: 100-106.
40. Maini MK, Schurich A. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J. Hepatol. 2010; 52: 616-619.
41. Han Q, Zhang C, Zhang J, Tian Z. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology 2011; 54: 1179-1189.
42. Ebert G, Poeck H, Lucifora J etal. 5′ Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice. Gastroenterology 2011; 141: 696-706, e1-3.